Baidu
map

内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

Diabetes Care：2型糖尿病餐前胰岛素注射后可即刻进餐

2013-01-28 Diabetes Care 《糖尿病护理》杂志 CDS

2型糖尿病胰岛素糖化血红蛋白
关注

　　在临床上，2型糖尿病患者在注射胰岛素后，需要等待10~30分钟再进餐。然而，近期发表的一项随机、开放交叉研究提示，对于用人胰岛素进行餐前胰岛素治疗的2型糖尿病患者，胰岛素注射后至进餐的时间间隔（IMI）完全不必要。（Diabetes Care.2013年1月22日在线版） 　　该研究入组100例2型糖尿病患者，随机分入IMI优先组（即先间隔20 min，后取消时间间隔）和

　　在临床上，2型糖尿病患者在注射胰岛素后，需要等待10~30分钟再进餐。然而，近期发表的一项随机、开放交叉研究提示，对于用人胰岛素进行餐前胰岛素治疗的2型糖尿病患者，胰岛素注射后至进餐的时间间隔（IMI）完全不必要。（Diabetes Care.2013年1月22日在线版）

　　该研究入组100例2型糖尿病患者，随机分入IMI优先组（即先间隔20 min，后取消时间间隔）和IMI最后组（与优先组相反）。研究者发现，忽略IMI仅致糖化血红蛋白（HbA1c）水平轻度升高，由于差异并不具有临床意义，取消IMI的胰岛素治疗方案并不劣于有IMI的方案。在轻微低血糖发生率和血糖参数方面，有无IMI差别不大。取消IMI后，患者对治疗的满意度明显升高，但生活质量总评分并无明显改善。研究者报告，86.5%的受试者更愿意接受无IMI的胰岛素治疗方案。 


Randomized Crossover Study to Examine the Necessity of an Injection-to-Meal Interval in Patients With Type 2 Diabetes Mellitus and Human Insulin

OBJECTIVE 
Patients with diabetes and insulin therapy with human insulin were usually instructed to use an interval of 20–30 min between the injection and meal. We examined the necessity of the injection-to-meal interval (IMI) in patients with type 2 diabetes mellitus (T2DM) and flexible insulin therapy with human insulin.
RESEARCH DESIGN AND METHODS 
In this randomized, open crossover trial, 100 patients with T2DM (47% men, mean age = 66.7 years) were randomized to the IMI first group (phase 1, IMI 20 min; phase 2, no IMI) or IMI last group (phase 1, no IMI; phase 2, IMI 20 min). The main outcome measures were HbA1c, blood glucose profile, incidence of hypoglycemia, quality of life, treatment satisfaction, and patient preference.
RESULTS 
Forty-nine patients were randomized to the IMI first group and 51 patients to the IMI last group. Omitting the IMI only slightly increases HbA1c (average intraindividual difference = 0.08% [CI 0.01–0.15]). Since the difference is not clinically relevant, a therapy without IMI is noninferior to its application (P < 0.001). In the secondary outcomes, the incidence of mild hypoglycemia also did not differ between no IMI and IMI significantly (mean of differences = −0.10, P = 0.493). No difference in the blood glucose profile of both groups was found. Treatment satisfaction increased markedly, by 8.08, if IMI was omitted (P < 0.001). The total score of the quality of life measure did not show differences between applying an IMI or not. Insulin therapy without IMI was preferred by 86.5% of patients (P < 0.001).
CONCLUSIONS 
An IMI for patients with T2DM and preprandial insulin therapy is not necessary.

    

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2069918, encodeId=f326206991859, content=<a href='/topic/show?id=1cbf839029d' target=_blank style='color:#2F92EE;'>#胰岛素注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83902, encryptionId=1cbf839029d, topicName=胰岛素注射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Tue Nov 05 15:51:00 CST 2013, time=2013-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749391, encodeId=fe5d1e49391cb, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 25 23:51:00 CST 2013, time=2013-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759241, encodeId=2bf41e5924142, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Sep 06 00:51:00 CST 2013, time=2013-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901048, encodeId=f508190104800, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Nov 07 23:51:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636622, encodeId=d9401636622e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 17 14:51:00 CST 2013, time=2013-10-17, status=1, ipAttribution=)]
    2013-11-05 cathymary

    #胰岛素注射#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2069918, encodeId=f326206991859, content=<a href='/topic/show?id=1cbf839029d' target=_blank style='color:#2F92EE;'>#胰岛素注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83902, encryptionId=1cbf839029d, topicName=胰岛素注射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Tue Nov 05 15:51:00 CST 2013, time=2013-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749391, encodeId=fe5d1e49391cb, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 25 23:51:00 CST 2013, time=2013-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759241, encodeId=2bf41e5924142, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Sep 06 00:51:00 CST 2013, time=2013-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901048, encodeId=f508190104800, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Nov 07 23:51:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636622, encodeId=d9401636622e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 17 14:51:00 CST 2013, time=2013-10-17, status=1, ipAttribution=)]
    2013-11-25 baoya

    #胰岛#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2069918, encodeId=f326206991859, content=<a href='/topic/show?id=1cbf839029d' target=_blank style='color:#2F92EE;'>#胰岛素注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83902, encryptionId=1cbf839029d, topicName=胰岛素注射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Tue Nov 05 15:51:00 CST 2013, time=2013-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749391, encodeId=fe5d1e49391cb, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 25 23:51:00 CST 2013, time=2013-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759241, encodeId=2bf41e5924142, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Sep 06 00:51:00 CST 2013, time=2013-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901048, encodeId=f508190104800, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Nov 07 23:51:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636622, encodeId=d9401636622e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 17 14:51:00 CST 2013, time=2013-10-17, status=1, ipAttribution=)]
    2013-09-06 ms5439512287675881

    #BET#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2069918, encodeId=f326206991859, content=<a href='/topic/show?id=1cbf839029d' target=_blank style='color:#2F92EE;'>#胰岛素注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83902, encryptionId=1cbf839029d, topicName=胰岛素注射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Tue Nov 05 15:51:00 CST 2013, time=2013-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749391, encodeId=fe5d1e49391cb, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 25 23:51:00 CST 2013, time=2013-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759241, encodeId=2bf41e5924142, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Sep 06 00:51:00 CST 2013, time=2013-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901048, encodeId=f508190104800, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Nov 07 23:51:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636622, encodeId=d9401636622e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 17 14:51:00 CST 2013, time=2013-10-17, status=1, ipAttribution=)]
    2013-11-07 智慧医人

    #Diabetes#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2069918, encodeId=f326206991859, content=<a href='/topic/show?id=1cbf839029d' target=_blank style='color:#2F92EE;'>#胰岛素注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83902, encryptionId=1cbf839029d, topicName=胰岛素注射)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Tue Nov 05 15:51:00 CST 2013, time=2013-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749391, encodeId=fe5d1e49391cb, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 25 23:51:00 CST 2013, time=2013-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759241, encodeId=2bf41e5924142, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Sep 06 00:51:00 CST 2013, time=2013-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901048, encodeId=f508190104800, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Nov 07 23:51:00 CST 2013, time=2013-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636622, encodeId=d9401636622e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 17 14:51:00 CST 2013, time=2013-10-17, status=1, ipAttribution=)]
    2013-10-17 爆笑小医

    #DIA#

    0

相关资讯

JAMA：强化减肥干预或可部分缓解2型糖尿病

通过生活方式干预而达到2型糖尿病的缓解率有多大，迄今尚不清晰。为了评估长期强化减肥干预与2型糖尿病至糖尿病前期或血糖量正常的缓解率之间的关系，亚特兰大疾病控制与预防中心的Edward W. Gregg, Ph.D.及其同事开展了相关研究。他们的研究结果于2012年12月19日在线刊发于《美国医学会杂志》，显示在体重超重的成年人中，参与强化的生活方式干预（它包括了辅导课程及设定减少热卡摄入及增加身体

Nature：揭示二甲双胍降糖新机制

　　《自然》（Nature）杂志近期发表的一项研究揭示了二甲双胍潜在的降糖新机制。此前的理论认为二甲双胍通过激活AMPK从而减少肝脏葡萄糖合成，而新的研究表明，二甲双胍通过诱导AMP和抑制腺苷酸环化酶的核苷酸在肝细胞内聚集，降低cAMP和PKA活性，PKA关键蛋白磷酸化步骤被阻止，因而肝细胞胰高血糖素依赖的葡萄糖输出被抑制。 　　研究由宾夕法尼亚大学Perelman医学院糖尿病、肥胖和代谢

PLoS Genet:面对2型糖尿病，胖瘦是否有区别？

体型肥胖者罹患2型糖尿病通常可以从胰岛素抵抗角度解释，然而为什么体型瘦弱的人同样会得糖尿病?2012年5月的PLoS Genet杂志上刊出了一篇论文就探寻了瘦人和胖人在2型糖尿病发病上的差异(PLoS Genet. 2012 May;8(5):e1002741)。 该研究旨在通过对2型糖尿病病例按BMI分层，来确认LAMA1基因的遗传风险变异，并发现瘦人体内更多的风险变异。毫无疑问，弄清楚瘦

BMC Endocr Disord:强化降糖发生低血糖的预测因素

　　德国研究者进行的一项前瞻性研究（BMC Endocr Disord. 2012 Oct 17;12(1):23）表明，低血糖是接受强化降糖治疗的2型糖尿病门诊患者的常见并发症。既往发生过低血糖、微血管疾病（如视网膜病变）和接受胰岛素治疗的患者，尤其需要注意预防低血糖发生。服用噻唑烷二酮类药物、DPP-4抑制剂与GLP-1类似物的患者发生低血糖的

J Diabetes：糖尿病治疗模式变革即将到来？

■ 控制血糖并非唯一目标，药物选择应权衡风险与获益 　　治疗模式变革，SU及其替代疗法作用或需重新评估 　　自退伍军人糖尿病研究(VADT)、控制糖尿病患者心血管风险行动研究(ACCORD)和糖尿病治疗与心血管保护行动：培哚普利/吲达帕胺复方制剂与格列齐特缓释片对照评估研究(ADVANCE)结果发表3～4年后，更多研究者认识到，针对所有糖尿病人群制定单一的血糖控制目标可能不妥，这大

Int Urol Nephrol：2型糖尿病患者肾活检有效性评价

　　糖尿病（DM），肾病糖尿病肾病（DN）和非糖尿病肾病（NDRD）的治疗方式与疗效不尽相同，对于这三种疾病的鉴别诊断就尤为重要。最近一项针对不同年龄组别2型糖尿病患者肾活检有效性的研究指出，不同年龄组别的临床表现和病例学检查结果不尽相同，肾活检对确定糖尿病肾损害和患者管理有实际意义。 　　研究者分析了216位2型糖尿病患者的肾组织标本和临床与实验室检查数据。年龄分组分别为17-35岁（组1），

Baidu
map
Baidu
map
Baidu
map